Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Explore practical guidance on the first crypto to buy as a beginner, including risk considerations and a simple decision framework.
26,337 articlesA biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
In this stock market today update, Intel pulls back as AI bubble risk concerns rise, even as AI-driven momentum suppo...
A rival’s blowout earnings stirred optimism across hardware names. This piece breaks down why super micro computer st...
A federal court hearing in New York is set to scrutinize how the government plans to deliver refunds from the $166 bi...
Energy Fuels stock is catching a strong bid as investors react to fresh progress in its rare-earths unit and a broade...
As Salesforce unveils a strategic acquisition, investors are asking whether this move can truly beat the current SaaS...
On July 1, Meta Platforms lit up the market with a 9% jump that pushed the stock toward $612.91. The move followed re...
A quiet pivot from consumer devices to AI infrastructure has propelled this former smartphone maker into the spotligh...
Across Chicago and beyond, AI readiness in schools mirrors economic divides. This report examines funding gaps, acces...
A neighbor’s request to borrow a snowblower tests whether sharing costly equipment makes financial sense. The article...
Trump’s historic line about abandoning nation-building now echoes into a markets-focused era. This piece explains wha...
Capital One faces headwinds, but strategic shifts in risk management, digital growth, and funding could unlock market...